Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

To Assess the Efficacy and Safety of SCD-044 in the Treatment of Moderate to Severe Atopic Dermatitis

ClinicalTrials.gov ID: NCT04684485

Public ClinicalTrials.gov record NCT04684485. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 1:41 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of SCD-044 in the Treatment of Moderate to Severe Atopic Dermatitis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a Phase II, randomized, double-blind, placebo-controlled study in subjects with moderate to severe atopic dermatitis.

Study identification

NCT ID
NCT04684485
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
250 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 29, 2021
Primary completion
Nov 10, 2024
Completion
Mar 17, 2025
Last update posted
Dec 29, 2025

2021 – 2025

United States locations

U.S. sites
34
U.S. states
10
U.S. cities
26
Facility City State ZIP Site status
Omni Dermatology Phoenix Arizona 85018
Yuma Clinical Trials, LLC Yuma Arizona 85364
T. Joseph Raoof Md, Imc./Encino Research Center Encino California 91436
Metropolis Dermatology Los Angeles California 90017
Axis Clinical Trials Los Angeles California 90036
Providence Clinical Research North Hollywood California 91606
Unison Clinical Trials Sherman Oaks California 91403
Providere' Research Inc. West Covina California 91790
Clarity Dermatology Castle Rock Colorado 80109
Accel Research Sites Network - Annexus Dermatology & Aestheitcs DeLand Florida 32720
Revival Research Corporation Doral Florida 33122
Advanced Clinical Research Institute Florida City Florida 33607
FXM Clinical Research Fort Lauderdale Fort Lauderdale Florida 33308
Direct Helpers Research Center Hialeah Florida 33012
Evolution Research Center Hialeah Florida 33012
Sweet Hope Research Specialty, Inc, d/b/a Neoclinical Research Hialeah Florida 33016
Evolution Clinical Trials, Inc Hialeah Gardens Florida 33016
Advanced Clinical Research Network, Corp Miami Florida 33135
MedOne Clinical Research, LLC Miami Florida 33145
Century Research LLC Miami Florida 33173
FXM Clinical Research Miami Miami Florida 33175
JD Medical Group, LLC Miami Florida 33176
FXM Clinical Research Miramar Miramar Florida 33027
Adtremed Inc Tampa Florida 33607
Alliance Clinical Research of Tampa Tampa Florida 33615
Oracle Clinical Research College Park Georgia 30349
Physicians Research Group West Lafayette Indiana 47906
Revival research Institute, LLC Troy Michigan 48084
DFW Clinical Research Dallas Texas 75234
3A Research El Paso Texas 79902
SMS Clinical Research Mesquite Texas 75149
Stride Clinical Research Sugar Land Texas 77479
Springville Dermatology/ CCT Research Springville Utah 84663
Skin DC Derm Arlington Virginia 22209

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 24 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04684485, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 29, 2025 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04684485 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →